< Back to previous page
Publication
High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib
Book Contribution - Book Abstract Conference Contribution
Book: JOURNAL OF CLINICAL ONCOLOGY
Volume: 36
Number of pages: 1